Eye Journal
In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study – (Eye 29, 1099 (August 2015))
In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study Eye 29, 1099 (August 2015). doi:10.1038/eye.2015.103 Authors: Y Qazi, A Kheirkhah, C Blackie, A Cruzat, M Trinidad, C Williams, D R Korb & P Hamrah
Regarding ‘transient visual loss due to reversible ‘pending’ central retinal artery occlusion in occult giant cell arteritis’ – (Eye 29, 1111 (August 2015))
Regarding ‘transient visual loss due to reversible ‘pending’ central retinal artery occlusion in occult giant cell arteritis’ Eye 29, 1111 (August 2015). doi:10.1038/eye.2015.55 Author: A Alwitry
Chorio-retinal thickness measurements in patients with acromegaly – (Eye 29, 1111 (August 2015))
Chorio-retinal thickness measurements in patients with acromegaly Eye 29, 1111 (August 2015). doi:10.1038/eye.2015.56 Authors: K X Cheong & C S H Tan
Effect of cooling proparacaine 0.5% eye drops on patient’s comfort during instillation – (Eye 29, 1112 (August 2015))
Effect of cooling proparacaine 0.5% eye drops on patient’s comfort during instillation Eye 29, 1112 (August 2015). doi:10.1038/eye.2015.59 Authors: J Hu Youwei & B Chang
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA – (Eye 29, 1113 (August 2015))
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA Eye 29, 1113 (August 2015). doi:10.1038/eye.2015.68 Authors: D Călugăru & M Călugăru